Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
102
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Verastem Inc market cap is $797.67M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Verastem Inc 52 week high is $10.82 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Verastem Inc 52 week low is $3.43 as of November 22, 2026.
Verastem Inc stock price today is $6.33.
Verastem Inc stock price yesterday was $6.86.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Verastem Inc's P/E ratio is -3.42.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Verastem Inc P/B ratio is 59.2031.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Verastem Inc 50-day moving average is $8.41.